Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Radiology and Oncology
Volume 50 (2016): Issue 3 (September 2016)
Open Access
The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients
Mariarosa Pascale
Mariarosa Pascale
,
Cinzia Aversa
Cinzia Aversa
,
Renzo Barbazza
Renzo Barbazza
,
Barbara Marongiu
Barbara Marongiu
,
Salvatore Siracusano
Salvatore Siracusano
,
Flavio Stoffel
Flavio Stoffel
,
Sando Sulfaro
Sando Sulfaro
,
Enrico Roggero
Enrico Roggero
,
Serena Bonin
Serena Bonin
and
Giorgio Stanta
Giorgio Stanta
| Jul 19, 2016
Radiology and Oncology
Volume 50 (2016): Issue 3 (September 2016)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Research Article
Published Online:
Jul 19, 2016
Page range:
313 - 320
Received:
Feb 08, 2016
Accepted:
Apr 28, 2016
DOI:
https://doi.org/10.1515/raon-2016-0033
© 2016 Radiol Oncol
This content is free.
Mariarosa Pascale
Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
Cinzia Aversa
Department of Medical Sciences, University of Trieste, Cattinara Hospital, Trieste, Italy
Renzo Barbazza
Department of Medical Sciences, University of Trieste, Cattinara Hospital, Trieste, Italy
Barbara Marongiu
Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
Salvatore Siracusano
Department of Medical Sciences, University of Trieste, Cattinara Hospital, Trieste, Italy
Flavio Stoffel
Department of Urology, Ospedale San Giovanni, Bellinzona, Switzerland
Sando Sulfaro
Department of Laboratory Medicine, S.C. Pathology, Santa Maria degli Angeli Hospital, Pordenone, Italy
Enrico Roggero
Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
Serena Bonin
Department of Medical Sciences, University of Trieste, Cattinara Hospital, Trieste, Italy
Giorgio Stanta
Department of Medical Sciences, University of Trieste, Cattinara Hospital, Trieste, Italy